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Healthcare-Associated Meningitis 
Caused by M. tuberculosis and 
Non-Tuberculous Mycobacteria
Ashit Bhusan Xess, Kiran Bala and Urvashi B. Singh
Abstract
Meningitis can be acquired in the community setting or secondary to invasive 
procedures or head trauma. The latter group has been classified as health-care-
associated meningitis because the etiologic agents belong to a different spectrum of 
microorganisms, including Staphylococcus aureus, Coagulase negative staphylococ-
cus Gram negative bacilli, Aspergillus, Candida albicans, Cryptococcus neoformans. 
IDSA Clinical Practice guidelines for Healthcare-associated ventriculitis and men-
ingitis does not include M. tuberculosis and NTM, but in the last decade infections 
caused by these organisms are on a rise. These infections are mostly associated with 
cerebrospinal fluid shunts, cerebrospinal fluid drains, intra-thecal drug therapy, 
deep brain stimulation hardware, neurosurgery and head trauma. Most commonly 
these are introduced during surgical procedures. Another important pathogenic 
factor is biofilm formation that increases the persistence and resistance to antibiotic 
therapy, hence the survival. A high index of suspicion aids early diagnosis but pre-
ventive measures such as care of the devices introduced into sterile spaces is essen-
tial. Sterilization of the critical items is recommended by treating with different 
chemical sterilizing agents but most importantly meticulous cleaning must precede 
any high-level disinfection or sterilization process. A course of multidrug therapy is 
required for prolonged period of time depending on mycobacterial species.
Keywords: non-tuberculous mycobacteria, Mycobacterium tuberculosis,  
hospital acquired infections, iatrogenic infections
1. Introduction
Healthcare-associated CNS infection mostly includes meningitis, ventriculitis, 
subdural empyema and brain abscess. With increased use of intracranial devices and 
increase in number of patients requiring neurosurgery, the risk of acquiring these 
infections has increased. While these devices generally being sterile, they can provide 
a route for microorganism during placement, handling or maintenance. The most 
common causative agents are Staphylococcus aureus, coagulase negative staphylococ-
cus, Gram-negative bacteria, candida species, Cryptococcus neoformans, etc. In the 
last decade, Mycobacterium tuberculosis and non-tuberculous mycobacterium are 
gaining prominence in causing healthcare-associated CNS infections. These organisms 
especially non-tuberculous mycobacterium are found in environment which once find 
entry into CNS can cause infections. No approved treatment guidelines are present 
for the treatment of non-tuberculous mycobacterium. So one must take utmost care 
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in maintaining these intracranial devices from not acquiring these infections. These 
devices and neurosurgical devices come under critical category as per Spaulding classi-
fication, so stringent decontamination and sterilization procedures have to be followed 
to render them sterile.
2. Meningitis
Meningitis is an acute inflammation of the protective membranes covering the 
brain and spinal cord known collectively as the meninges which consists of durama-
ter, arachnoid mater and pia mater [1].
The patient with meningitis usually presents with fever, headache, altered sen-
sorium, behavioral changes, focal neurological signs or seizures. There are various 
signs that can be elicited in meningitis patients such as nuchal rigidity, Kernig’s sign 
and Brudzinski’s sign. Nuchal rigidity or neck rigidity is elicited when neck resists 
passive flexion. Kernig’s sign is elicited on a supine position where knees are flexed 
onto the abdomen. Any attempt to extend the knee from this position causes pain in 
the patient. Brudzinski’s sign is also elicited in supine position where trying to flex the 
neck causes flexion at the knee and hip joints. These signs indicate there is meningeal 
irritation in the patient. But both these tests are uncertain in some cases such as in very 
young or old patients, immunocompromised or patients with depressed mental status.
Meningitis can be divided into acute, subacute and chronic meningitis. Acute 
meningitis is mostly caused by bacteria whereas subacute and chronic also include 
viral, fungal and parasitic causes. In cases of acute meningitis most common causes 
are Neisseria meningitides, Streptococcus pneumoniae, Escherichia coli, Pseudomonas 
aeruginosa, Staphylococcus species, Listeria monocytogenes, Haemophilus influenzae, 
Streptococcus agalactiae, Bacteroides fragilis and Fusobacterium species. Viral causes 
include Enteroviruses, Herpes Zoster virus, Herpes Simplex viruse 2, Epstein Barr 
virus, Human Immunodeficiency virus (Table 1).
Organisms causing subacute meningitis consists of Mycobacterium tuberculosis, 
Cryptococcus neoformans, Histoplasma capsulatum, Coccidioides immitis and Treponema 
pallidum. Bacterial agents causing chronic meningitis are Mycobacterium tuberculosis, 
Borrelia burgdorferi and Treponema pallidum. Fungal agents comprises of Cryptococcus 
neoformans, Coccidiodes immitis, Candida species, Histoplasma capsulatum, Blastomyces 
dermatitidis, Aspergillus species and Sporothrix schenckii. Helminthic causes are Taenia 
solium, Gnathostoma spinigerum, Angiostrongylus cantonensis [2].
2.1 Healthcare-associated meningitis
Meningitis can be acquired in community settings or in hospital settings via inva-
sive procedures performed or through head trauma. In hospital settings the causative 
agents are totally different from those acquired in community settings. In many of the 
cases the symptoms appear after discharge from the hospital. There are many ways in 
which a patient can acquire meningitis in a hospital settings which are as follows [3]:
• CSF shunts
• CSF drains
• Intrathecal infusion pumps
• Deep brain stimulation hardware
• Neurosurgery
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2.1.1 Cereberospinal fluid shunts
CSF shunt is a system in which the proximal part of it is in the cerebral ventricle, 
subdural space, intracranial cyst or lumbar arachnoid space whereas the distal end 
is in the peritoneal, pleural or vascular space. A part of the system has a pressure 
regulating valve which usually is present just outside the skull or in the distal part of 
the system. Additional connecting systems may be present which facilitates connec-
tion of more catheters or devices [4].
The incidence of CSF shunt infections may show huge variations in various 
studies but it usually ranges from 4 to 17% [5, 6]. Factors associated with CSF shunt 
infections can be divided into preoperative and operative causes. Preoperative 
causes includes premature birth associated with intraventricular hemorrhage, 
younger age, previous shunt infections, hydrocephalus caused by purulent men-
ingitis, hemorrhage or myelomeningocele. Operative causes are inexperienced 
neurosurgeon, movement of people during procedure, perforated surgical gloves, 
neuroendoscope use, longer duration of procedure, insertion of catheter below 
T7 vertebral body in case of ventriculoarterial shunting, improper patient skin 
Table 1. 
Causative agents of meningitis.
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preparation, shaving of skin, large areas of skin exposed during procedure and 
repeated shunt revision surgeries [7, 8].
There are 4 possible mechanisms by which CSF shunts can get infected. First 
and most frequent mechanism is colonization of the shunt during surgery. The 
second mechanism is retrograde infection from the distal end of the shunt. This 
can be due to bowel perforation or surgeries being conducted in gastrointestinal 
tract or genitourinary tract. Due to the breach in the GI tract there is a possibility 
of retrograde infections by microbial flora of GI tract. Third mechanism is through 
skin after injection of drug into ventricular reservoir or assess potency. Fourth 
mechanism is through haematogenous seeding in cases of ventriculoarterial shunts 
wherein bacteremia is the cause of retrograde infections [3].
2.1.2 Cerebrospinal fluid drains
CSF drains are temporary catheters used to divert CSF externally into a 
collecting bag. These are used in the temporary management of elevated intra-
cranial pressure due to acute hydrocephalus secondary to intracranial hemor-
rhage, neoplasm, obstruction of the CSF circulation or trauma. The proximal 
end of the catheter is usually situated in the cerebral ventricle, subdural space, 
intracranial cyst or lumbar subarachnoid space. The distal end is connected 
to a collecting system which consists of a drip chamber, ports for measuring 
intracranial pressure, ports for sampling and collecting bag. Studies have shown 
the incidence rates may range from 0 to 22%. In a study by Ramanan et al., the 
overall external ventricular drain related infection was found to be 11.4 per 
1000 catheter days [9].
Factors associated with increased risk of infections in external CSF drains are 
intraventricular or subarachnoid hemorrhage, cranial fracture with CSF leak, 
catheter irrigation, craniotomy and duration of catheterization. Mechanisms 
generally include introduction of microorganism during the procedure, by retro-
grade infections through exit ports and during flushing of the tubings to maintain 
patency [3].
2.1.3 Intrathecal infusion pumps
Intrathecal infusion pumps are used as drug delivery systems in conditions such 
as cerebral palsy, multiple sclerosis, trauma, hereditary spastic paraplegia to deliver 
baclofen in order to relieve the spasticity. Through these delivery systems opiates 
are administered in management of intractable pain usually in cases of malignancy. 
The catheter of these pumps are inserted at the lumbar region and passed intrathe-
cally to the point where drug has to be delivered. Generally these pumps are placed 
subcutaneously in the abdomen region but in pediatric patients these devices are 
placed under the abdominal fascia. These pumps have to be refilled from time to 
time transcutaneously with the desired drug [3].
Majority of the cases who get infected or contract meningitis consists of pedi-
atric patients [10, 11]. Majority of the infections occur within 2 months of surgery 
but it can happen anytime in the next 3–6 months where drug is refilling is being 
done. Infection rates may vary from 3.6% in subfacially placed pumps to 20% in 
subcutaneously placed pumps [12]. In many studies it is seen that it is difficult to 
distinguish meningitis from local infections. In a study out of 207 children with 
infusion pumps 25 had suspected superficial infections, 13 had deep seated infec-
tions and only 2 of them had meningitis [13]. Route of entry for these infections are 
during surgery or during refilling of the pumps.
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2.1.4 Deep brain stimulation hardware
Deep brain stimulation is used in cases of parkinsonism, dystonia, essential 
tremors and obsessive-compulsive disorders. This whole set up consists of intra-
cranial lead, connector and a pulse generator implanted in infraclavicular area. In 
cases of intractable focal epilepsy cortical and depth electrodes are placed which not 
only detects abnormal electroencephalographic activity but also delivers patterned 
electrical stimuli to interrupt seizures.
The infections can occur during initial surgery or following surgery performed 
in order to replace the battery. The infection of pulse generator is the most common 
infection. There might be a retrograde infection from the pulse generator which can 
cause meningitis. The incidence of infection may vary from 0.62 to 14.3% and may 
involve all the 3 components of the device [14].
2.1.5 Neurosurgery
In cases of neurosurgery there is higher risk of ventriculitis and meningitis since 
there is direct manipulation of central nervous system. So the infections can be 
introduced during surgical procedure through various instruments or even surgeons 
themselves. The instruments may be at fault if they are not sterilized. Surgeons 
on the other hand if are not following proper hand washing practices might be 
the source of infection. In a study conducted in Taiwan the incidence of bacterial 
meningitis in a tertiary care hospital was 48% [15].
According to 2017 IDSA Clinical Practice Guidelines for Healthcare-Associated 
Ventriculitis and Meningitis all the above organisms mentioned in Table 2 are 
common agents of healthcare-associated meningitis. Mycobacterium tuberculosis 
and non-tuberculous mycobacterium does not find mention in the above list. But 
there are adequate number of cases wherein Mycobacterium species especially non-
tuberculous mycobacterium are causative agents of nosocomial meningitis.
2.2 Mycobacterium tuberculosis and non-tuberculous mycobacterium (NTM)
Traditionally Mycobacterium species has been classified according to phenotypic 
characteristics (Table 3) but with the advent of molecular studies characterization 
Table 2. 
Causative agents of healthcare acquired meningitis.
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of these organisms are done at genetic level. The organisms belonging to genus 
Mycobacterium are aerobic, non-spore forming, non-motile, thin, slightly 
curved or straight rods. Mycobacterium species have a cell wall comprising of 
N-glycolylmuramic acid which has a very high lipid content. Because of this 
property it creates a hydrophobic permeability barrier. The growth rate of these 
organisms is very slow because of their hydrophobic cell surface. Because of the 
hydrophobicity these organisms tend to clump with each other which results in 
reduced diffusion of nutrients into the cell. The generation time for mycobacterium 
is about 20–36 h [16].
2.3 Mycobacterium tuberculosis and healthcare-associated infections
M. tuberculosis is the major cause of infectious health burden in the whole world. 
In the developing countries tuberculosis is a major concern in the population. 
Tuberculosis not only involves the respiratory system but also every system in the 
body. This is why tuberculosis is not only a health burden but also a social burden 
and economic burden on any nation.
M. tuberculosis becomes more lethal because of its latency. It is capable of going 
into a phase of latency wherein there are no symptoms at all to suggest the patient 
is infected. When the patients’ immune system weakens these organisms find an 
opportunity to reactivate and affect any organ system in the body. Patients who 
come for different conditions to the hospital have weakened immune system. So it 
might so happen that these organisms may reactivate and affect the patient.
Table 3. 
Classification of genus Mycobacterium.
7Healthcare-Associated Meningitis Caused by M. tuberculosis and Non-Tuberculous Mycobacteria
DOI: http://dx.doi.org/10.5772/intechopen.87119
A study has shown that M. tuberculosis has been majorly involved in prosthetic 
joint infections [17]. In this study 53% of the cases were hip joint infections, 40.9% 
cases involved knee joint and rest were other joints. One reason could be that 
in patients with latent infections the infected monocytes migrate towards sites 
of inflammation i.e. surgical sites and cause prosthetic joint infections [18, 19]. 
Another reason could be that surgical trauma could break down old granulomas 
and hence reactivation of tuberculosis in the joints [20, 21].
Another site that M. tuberculosis is known to infect is the pacemaker implan-
tation site. In a study by Al-Ghamdi it was found out of 25 cases of pacemaker 
implantation site infection 8 cases comprised of M. tuberculosis infection and others 
were NTM [22]. These sites were infected via haematogenous route.
2.4 Non-tuberculous mycobacteria and healthcare acquired infections
The NTM group consists of more than 172 different species implicated in dif-
ferent clinical conditions (http://www.bacterionet/mycobacterium.html). NTM 
are important environmental opportunistic pathogens of humans and animals 
including poultry and fish. The NTM are ubiquitous in nature and are found in 
various habitats. In the past few years NTM are isolated from natural sources like 
water, soil, animals, milk, food products and from artificial resources such as water 
distribution systems and sewer [23, 24].
Unlike Mycobacterium tuberculosis, notification of NTM is not mandatory 
because of which accurate knowledge of impact of NTM on public health is 
unknown. The impact of NTM is significantly seen in immunocompromised 
patients e.g. AIDS and transplant patients as life-threatening opportunistic 
infections [25, 26]. Off late there has been a surge in pulmonary infections and 
hospital acquired infections (HAI) in immunocompetent patients suggesting the 
importance of NTM on human health [27–30]. NTMs are implicated in medical 
device related infections because of their biofilm capabilities [31]. Their ubiqui-
tous nature allows them to cause persistent infection in the patients in healthcare 
settings [32].
2.4.1 Non-tuberculous mycobacterium and biofilms
In the early days of Mycobacteriology Lowenstein and Calmette described 
the phenomenon of mycobacterial cells forming aggregates and pellicles [33, 34], 
whereas Robert Koch described these cells pressed together and arranged in bundles 
[35]. These were the earlier days when we see description which are similar to the 
picture of biofilm formation in the present day. The first report of modern concept 
of biofilms was published by costerton [36]. A decade later articles began to appear 
about environmental mycobacterial biofilms [37, 38].
Biofilm formation by mycobacteria are no different from the process by 
which other bacteria form biofilms. It starts with bacterial adhesion goes through 
stages of surface attachment, sessile growth, matrix synthesis and dispersion. 
Intercellular communication happens through quorum sensing [39]. However 
mycobacterial biofilms can form on air-liquid interface. This happens because 
of composition of extracellular matrix. The extracellular matrix consists of 
short mycolic acid which are hydrophobic in nature and because of this property 
biofilms are formed at the air-media interface [40]. In a study it has been shown 
maximum thickness for M. fortuitum and M. chelonae biofilm was detected by 72 h 
but other non-pigmented RGM reach maximum thickness by 96 h. M. chelonae 
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covers smaller surface area than M. abscessus, but greater area than M. fortuitum 
and M. margeritense. M. chelonae forms a biofilm which grows vertically whereas 
M. fortuitum covers the entire surface with thinner growth. Extensive cording is 
seen in M. abscessus and M. chelonae [41].
NTM are considered as etiological agents of healthcare-associated infec-
tions (HAI), which is a major public health concern. These are responsible for 
colonization of respiratory tract, infections related to medical procedures and 
disseminated infections in immunocompromised. Earlier M. avium used to be the 
main cause but RGMs like M. fortuitum, M. abscessus and M. chelonae are growing 
into prominence [42–44]. The main reason is biofilm formation by NTM. NTM 
organized in biofilms are hard to eradicate by common disinfection process 
and disinfectants such as chlorine, organomercurials, alkaline glutaraldehydes 
[43, 45–47]. Biofilms are also highly resistant to antimicrobial drugs and are able 
to modulate the host immune response [48]. This is due to physical barrier formed 
by the biofilm itself and also due to horizontal gene transfer between cells [49]. 
Bacteria also can switch their phenotypic stages causing a slower growth rate hence 
the effect of drugs acting on replicating organisms is nullified. These bacteria are 
known as persisters [50].
It has been proved in studies that NTM form biofilms on medical devices which 
in turn causes persistent infections. In a study it has been shown NTM form bio-
films on silicone which are used to coat medical devices e.g. endoscopes, catheters 
and air-liquid interface. Biofilms formed by M. fortuitum and M. abscessus have 
higher bacterial load than M. chelonae. M. fortuitum is considered as a good biofilm 
assembler [51].
2.5 Non-tuberculous mycobacteria and healthcare-associated meningitis
In the review of spectrum of CNS disease caused by RGM by Talati et al., 
[52] 19 cases of primary and secondary CNS infections were reported, fourteen 
cases were caused by M. fortuitum. Most common clinical presentation in the 
study was subacute meningitis, with symptom duration ranging from 3 days to 
5 months. There are other isolated reports, where Mycobacterium fortuitum is the 
cause of CNS infections. Table 4 summarizes cases isolated from CNS after VP 
shunt insertion. There are two other reported cases of VP shunt infection due to 
M. abscessus, a 30 yr. old male with hydrocephalus [53] and a 59-year-old man 
with hydrocephalus [54] (reported by us previously). Post insertion of VP shunt, 
the patients presented with meningeal signs and symptoms; but time duration for 
onset of symptoms varied from 8 days to months and in two cases, 16 and 30 years 
[55–58]. Other reports of cases of CNS infections due to M. fortuitum associated 
with intra-thecal pump infections, epidural catheter, balloon mitral valvotomy, 
chronic suppurative otitis media, mastoiditis, sacral trauma, meningioma resec-
tion have been published [59–61]. Literature reveals, only 6 cases of VP shunt due 
to M. fortuitum and M. abscessus (4, 2 cases respectively), causing CNS infections 
worldwide.
A 14 year old girl with high grade fever and altered sensorium was received in 
the emergency department of our institution. She had a past history of persistent 
headache and seizures. CT scan revealed posterior fossa glioma but could not be 
operated on since it was very near to the vital parts of the brain. So V-P shunt was 
placed in order to relieve the ventricular obstruction. After 3 years she underwent 
appendicectomy after which she started to have frequent convulsions. CT scan 
revealed dilated ventricles for which a revision shunt surgery was performed. But 
the symptoms were not relieved. Therefore shunt surgeries were performed without 
any improvement in the symptoms. In our institution we received the csf sample 
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Authors Country Age/Sex Underlying disease Mode of 
acquisition
Mycobacterial 
spp
Treatment Duration of 
therapy
Outcome
1. Chan et al  
(1991)[57]
Hong 
Kong
60yr/F Cerebral 
haemorrhage
V-A shunt M. fortuitum IV amikacin, ofloxacin 2.5 months Alive
2. Midani et al 
(1999)[56]
USA 13yr/ F Spina bifida V-P shunt M. fortuitum IV amikacin, cotrimoxazole 7.5 months Alive
3. Vishwanathan 
et al (2004)[58]
India 60 yrs/M Traumatic Brain 
injury
Ventriculo 
arterial 
shunt
M. fortuitum IV Kanamycin, ciprofloxacin 6 months Alive
4. Cadena et al 
(2014)[55]
USA 14 yrs/M Congenital 
hydrocephalus
V-P shunt M. fortuitum IV meropenem, oral 
cotrimoxazole, oral 
moxifloxacin
Alive
5. Baidya A, Singh U 
B (2016)[54]
India 59yrs/M Tubercular 
Meningitis/
hydrocephalus
V-P shunt M. abscessus IV amikacin, clarithromycin, 
meropenem
Shunt removal
One week Died
6. Montero et al 
(2016)[53]
USA 30yrs/M Hydrocephalus V-P shunt M. abscessus IV Azithromycin, 
Imipenem,amikacin
Shunt removal
Two years Alive
7. Present case India 14yrs/F Glioma/
Hydrocephalus
V-P shunt M. fortuitum IV Linezolid, ofloxacin, 
clofazimine, clarithromycin.
continuing Alive
Table 4.  
World reports of Rapidly growing mycobacteria isolated from Central Nervous System after insertion of VP shunt.
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and AFB was seen in ZN smear. On culturing on both MGIT and LJ media growth 
was seen within 7 days. MALDI-TOF identified the isolate as Mycobacterium fortui-
tum. The VP shunt was removed and she was started on Linezolid 10 mg/kg BD, 
Ofloxacin 20 mg/kg OD, Clofazimine 5 mg/kg OD, Clarithromycin 15 mg/kg BD 
according to IDSA guidelines on Diagnosis, Treatment and Prevention of Non-
tuberculous Mycobacterial Diseases. The patient started improving and her GCS 
scale improved.
The source of infection in such cases can be nosocomial, trauma, abscess, revi-
sion of shunt surgery, and any other surgery performed even after 30 years of VP 
shunt insertion [53].
NTMs form biofilms on silicone, stainless steel, polyvinyl chloride and 
polycarbonate of which mostly the present day surgical equipments, catheters 
and prosthesis comprise of [51, 62]. These come under critical items that enter 
the sterile space and vascular system. Sterilization of these critical items is 
recommended by treating with different chemical sterilizing agents but most 
importantly meticulous cleaning must precede any high-level disinfection or 
sterilization process.
2.6 Sterilization of medical devices
Spaulding classified the medical instruments as critical, semi-critical and non-
critical items (Table 5). Non-critical items consists of items which come in contact 
with patients’ intact skin for which surface disinfectants are enough for cleaning. 
As per critical, semi-critical items which come in contact with sterile spaces and 
mucous membranes thorough cleaning and disinfection is advised. Though steril-
ization is the ideal procedure recommended for these items, it is not always possible 
due to the composition of some of the items e.g. polypropylene. Hence high level 
disinfection is recommended for these items.
In cases of implants such as VP shunt, venous catheters, orthopedic implants etc. 
needs to be removed completely. Other than these all critical and semi-critical items 
are supposed to be treated with high level disinfectants to render it safe for reuse in 
the next patient (Table 6).
Table 5. 
Spaulding classification.
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3. Conclusion
Non-tuberculous mycobacteria may be rare causes of VP shunt-associated infec-
tions but should always be considered as a differential diagnosis. However, NTM 
does not find a mention as an offending organism nor any treatment protocols in 
the present IDSA guidelines for healthcare-associated ventriculitis and meningitis 
and management of ventriculo-peritoneal infections in adults. A high index of 
suspicion based on clinical presentation is essential to diagnose such rare pathogens.
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Instruments Used In Hospitals Sterilization/High Level Disinfection
• Ventriculoperitoneal shunt
• Ventriculoarterial shunt
• Dental implants
• Removal of implants [63].
• Cardiac /Urinary Catheters
• Implants
• Ultrsound Probes In Sterile  
Body Cavities
• Initial manual cleaning with a detergent (soak for 30  
min)/enzyme.
• Rinse with sterile water.
• Blow completely dry with compressed air.
• Repackage in sealed envelope.
• Sterilize with Ethylene Oxide
• Aerate catheters for at least 14 days at room temperature [64, 65].
• Laproscopes
• Arthroscopes
• Cystoscopes
• Initial manual cleaning with detergent/enzyme. Or
• Automated washer/disinfector containing peraccetic acid as liquid 
disinfectant.
• Soak in 2% Glutaraldehyde for 15-20 mins. Or
• Orthophthaldehyde (low vapour pressure). Or
• Gas plasma technology [66, 67].
• Use of sterile water for terminal rinsing.
• G.I. endoscopes
• Bronchoscopes
• Nasopharyngoscopes
• Clean mechanically internal and external surfaces with detergent/
enzymes
• Soak in 2% Glutaraldehyde for 15-20 min Or
Orthophthaldehyde for 12 min Or
2% Glutaraldehyde @ 25°C ×45 min Or
Ethylene Oxide sterilization [68–71].
• Rinse with sterile water.
• Dry and rinse the insertion tube and inner channels with alcohol 
and dry with forced air after disinfection.
Table 6.  
Sterilization Procedures for Instruments Used In Hospitals
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